(Total Views: 162)
Posted On: 06/25/2019 9:17:07 AM
Post# of 43729

$RGBP Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agonist To Treat for Inflammatory Bowel Disease
https://finance.yahoo.com/news/regen-biopharm...00199.html
https://finance.yahoo.com/news/regen-biopharm...00199.html


Scroll down for more posts ▼